Incorporating microglia‐like cells in human induced pluripotent stem cell‐derived retinal organoids
Journal of Cellular and Molecular Medicine · 2023-02 · 27 (3) · 435-445
DOI: 10.1111/jcmm.17670 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 16.01.2023. Verfasst von Valeria Chichagova und 16 weiteren Autor:innen. Beteiligte Einrichtung: Newcells Biotech, Newcastle upon Tyne, UK. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, Medical Research Council, National Centre for the Replacement, Refinement and Reduction of Animals in Research.
Abstract (Originalsprache)
Microglia are the primary resident immune cells in the retina. They regulate neuronal survival and synaptic pruning making them essential for normal development. Following injury, they mediate adaptive responses and under pathological conditions they can trigger neurodegeneration exacerbating the effect of a disease. Retinal organoids derived from human induced pluripotent stem cells (hiPSCs) are increasingly being used for a range of applications, including disease modelling, development of new therapies and in the study of retinogenesis. Despite many similarities to the retinas developed in vivo, they lack some key physiological features, including immune cells. We engineered an hiPSC co‐culture system containing retinal organoids and microglia‐like (iMG) cells and tested their retinal invasion capacity and function. We incorporated iMG into retinal organoids at 13 weeks and tested their effect on function and development at 15 and 22 weeks of differentiation. Our key findings showed that iMG cells were able to respond to endotoxin challenge in monocultures and when co‐cultured with the organoids. We show that retinal organoids developed normally and retained their ability to generate spiking activity in response to light. Thus, this new co‐culture immunocompetent in vitro retinal model provides a platform with greater relevance to the in vivo human retina.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Newcells Biotech, Newcastle upon Tyne, UK.
- Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
- Applied Sciences, Northumbria University, Newcastle upon Tyne, UK.
- F. Hoffmann-La Roche Ltd, Basel, Switzerland.
- Novartis, Basel, Switzerland.
- Merck Healthcare KGaA, Darmstadt, Germany.
ORCID-Profile: Valeria Chichagova
Förderung
- Biotechnology and Biological Sciences Research Council
- Medical Research Council
- National Centre for the Replacement, Refinement and Reduction of Animals in Research
- Medical Research Council Canada
Zitieren
APA
Chichagova, V., Georgiou, M., Carter, M., Dorgau, B., Hilgen, G., Collin, J., Queen, R., Chung, G., Ajeian, J., Moya-Molina, M., Kustermann, S., Pognan, F., Hewitt, P., Schmitt, M., Sernagor, E., Armstrong, L., & Lako, M. (2023). Incorporating microglia‐like cells in human induced pluripotent stem cell‐derived retinal organoids. Journal of Cellular and Molecular Medicine, 27(3), 435-445. https://doi.org/10.1111/jcmm.17670
Vancouver
Chichagova V, Georgiou M, Carter M, Dorgau B, Hilgen G, Collin J, et al. Incorporating microglia‐like cells in human induced pluripotent stem cell‐derived retinal organoids. Journal of Cellular and Molecular Medicine. 2023;27(3):435-445. doi:10.1111/jcmm.17670
BibTeX
@article{Chichagova2023,
author = {Chichagova, Valeria and Georgiou, Maria and Carter, Madeleine and Dorgau, Birthe and Hilgen, Gerrit and Collin, Joseph and Queen, Rachel and Chung, Git and Ajeian, Jila and Moya-Molina, Marina and Kustermann, Stefan and Pognan, Francois and Hewitt, Philip and Schmitt, Michael and Sernagor, Evelyne and Armstrong, Lyle and Lako, Majlinda},
title = {Incorporating microglia‐like cells in human induced pluripotent stem cell‐derived retinal organoids},
journal = {Journal of Cellular and Molecular Medicine},
year = {2023},
volume = {27},
number = {3},
pages = {435--445},
doi = {10.1111/jcmm.17670}
}
EUVIMED